Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome

  1. Katsuyoshi Horibata*,
  2. Yuka Iwamoto*,,
  3. Isao Kuraoka*,,
  4. Nicolaas G. J. Jaspers,
  5. Akihiro Kurimasa§,
  6. Mitsuo Oshimura,
  7. Masamitsu Ichihashi, and
  8. Kiyoji Tanaka*,,**
  1. *Laboratories of Organismal Biosystems, Graduate School of Frontier Biosciences, Osaka University, and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, 1-3 Yamadaoka, Suita, Osaka 565-0871, Japan; Department of Genetics, Medical Genetic Cluster, Erasmus University, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands; Departments of §Human Genome Science and Biomedical Science, Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Nishimachi 86, Yonago, Tottori 683-8503, Japan; and Division of Dermatology, Graduate School of Medicine, Kobe University, 7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
  1. Edited by Philip C. Hanawalt, Stanford University, Stanford, CA (received for review June 25, 2004)

Abstract

UV-sensitive syndrome (UVsS) is a rare autosomal recessive disorder characterized by photosensitivity and mild freckling but without neurological abnormalities or skin tumors. UVsS cells show UV hypersensitivity and defective transcription-coupled DNA repair of UV damage. It was suggested that UVsS does not belong to any complementation groups of known photosensitive disorders such as xeroderma pigmentosum and Cockayne syndrome (CS). To identify the gene responsible for UVsS, we performed a microcell-mediated chromosome transfer based on the functional complementation of UV hypersensitivity. We found that one of the UVsS cell lines, UVs1KO, acquired UV resistance when human chromosome 10 was transferred. Because the gene responsible for CS group B (CSB), which involves neurological abnormalities and photosensitivity as well as a defect in transcription-coupled DNA repair of UV damage, is located on chromosome 10, we sequenced the CSB gene from UVs1KO and detected a homozygous null mutation. Our results indicate that previous complementation analysis of UVs1KO was erroneous. This finding was surprising because a null mutation of the CSB gene would be expected to result in CS features such as severe developmental and neurological abnormalities. On the other hand, no mutation in the CSB cDNA and a normal amount of CSB protein was detected in Kps3, a UVsS cell line obtained from an unrelated patient, indicating genetic heterogeneity in UVsS. Possible explanations for the discrepancy in the genotype-phenotype relationship in UVs1KO are presented.

Footnotes

  • ** To whom correspondence should be addressed. E-mail: ktanaka{at}fbs.osaka-u.ac.jp.

  • Author contributions: K.H. and K.T. designed research; K.H., Y.I., I.K., N.G.J.J., A.K., M.O., M.I., and K.T. performed research; K.H., I.K., N.G.J.J., and K.T. analyzed data; and K.H. and K.T. wrote the paper.

  • This paper was submitted directly (Track II) to the PNAS office.

  • Abbreviations: CS, Cockayne syndrome; CSB, CS group B; GGR, global genome repair; HA, hemagglutinin antigen; NER, nucleotide excision repair; RRS, recovery of RNA synthesis; TCR, transcription-coupled DNA repair; UVsS, UV-sensitive syndrome; XP, xeroderma pigmentosum.

  • See Commentary on page 15273.

« Previous | Next Article »Table of Contents
From the Cover